Pharmacological evaluation of possible neuroprotective strategies in novel genetic mouse models of progressive neurodegeneration, based on tissue specific inducible Cre/loxP system

2011/03/B/NZ7/05949

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia
  • NZ3_5: Neurobiologia molekularna
  • NZ4_7: Neurofizjologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Farmakologii PAN

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Grzegorz Kreiner

Number of co-investigators in the project: 5

Call

OPUS 2 – announced on 2011-09-15

Amount awarded
471 000 PLN
Project start date
2012-08-22
Project end date
2016-04-21
Project duration
44 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. Aparat do analizy koordynacji ruchowej myszy (ROTAROD). Cost: 25 300 PLN
  2. GelX - Zautomatyzowany system dokumentacji żeli agarozowych. Cost: 27 100 PLN
  3. Komplet filtrów wzbudzania i pochłaniania do analizatora chemiluminescencji/fluorescencji (doposażenie istniejącej aparatury). Cost: 21 999 PLN
  4. Wytrząsarka laboratoryjna. Cost: 3 775 PLN

Information in the final report

Publication in academic press/journals (3)

  1. A neuroprotective phase precedes striatal degeneration upon nucleolar stress

    Authors:
    Kreiner G, Bierhoff H, Armentano M, Rodriguez-Parkitna J, Sowodniok K, Naranjo JR, Bonfanti L, Liss B, Schütz G, Grummt I, Parlato R
    Academic press:
    Cell Death & Differentiation - Cell Death Differ (year: 2013, volume: 20, pages: 1455-1464), Publisher: NPG - Nature Publishig Group
    Status:
    Published
    DOI:
    10.1038/cdd.2013.66 – link to the publication
  2. Nucleolar activity in neurodegenerative diseases: a missing piece of the puzzle ?

    Authors:
    Parlato R, Kreiner G
    Academic press:
    Journal of Molecular Medicine - J Mol Med (year: 2013, volume: 91, pages: 541-547), Publisher: Springer
    Status:
    Published
    DOI:
    10.1007/s00109-012-0981-1 – link to the publication
  3. Compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?

    Authors:
    Kreiner G
    Academic press:
    Frontiers in Cellular Neuroscience - Front Cell Neurosci (year: 2015, volume: Vol 9, 56, pages: 46028), Publisher: Frontiers Research Foundation
    Status:
    Published
    DOI:
    10.3389/fncel.2015.00056 – link to the publication

Articles in post-conference publications (9)

  1. Investigation of long-term effects of genetically evoked selective noradrenergic denervation on dopaminergic system functioning

    Authors:
    Jurga A, Rafa-Zabłocka K, Kot M, Daniel WA, Nalepa I, Kreiner G
    Conference:
    Neuronus 2013 IBRO&IRUN Neuroscience Forum, Kraków, Polska (year: 2013, pages: Book of Abstracts, 39), Publisher: n/a
    Date:
    conference 9-11.05
    Status:
    Published
  2. Mice with genetically evoked selective loss of noradrenergic system as a possible tool to study presmptomatic phase of Parkinson's Disease

    Authors:
    Kreiner G, Jurga A, Kot M, Rafa-Zabłocka K, Bagińska M, Parlato R, Scheutz G, Daniel WA, Nalepa I
    Conference:
    Dopamine 2013, Alghero, Włochy (year: 2013, pages: Program/Abstracts 151), Publisher: n/a
    Date:
    conference 24-28.05
    Status:
    Published
  3. Nucleolar activity in neurodegenrative diseases

    Authors:
    Kreiner G, Parlato R
    Conference:
    XVIII-th International Congress of the Polish Pharmacological Society, Kazimierz Dolny, Polska (year: 2013, pages: Pharmacol Rep, vol. 65 suppl., str. 10), Publisher: Pharmacological Reports / Elsevier
    Date:
    conference 23-25.05
    Status:
    Published
  4. Characterization of mice with genetically evoked selective degeneration of noadrenergic system and its possible influence on dopaminergic system

    Authors:
    Jurga A, Kreiner G, Rafa-Zabłocka K, Bagińska M, Parlato R, Schuetz G, Nalepa I
    Conference:
    XI International Symposium, Molecular basis of pathology and therapy in neurological disorders, Warszawa, Polska (year: 2012, pages: Symposium Abstract Book, 20), Publisher: n/a
    Date:
    conference 22-23.11
    Status:
    Published
  5. Noradrenergic signaling in Parkinson's disease

    Authors:
    Kreiner G
    Conference:
    Neurochemical Conference 2015 Neuropsychoimmunological mechanisms in the pathology of neurodegenerative diseases - from biomarkers to therapeutics, Warszawa, Polska (year: 2015, pages: Folia Neuropathol 53, 404), Publisher: Folia Neuropathologica
    Date:
    conference 22-23.10
    Status:
    Published
  6. Targeting nucleolus - a new approach in generating transgenic mouse models of neurodegenerative diseases and their exploitation to study possible neuroprotective therapies

    Authors:
    Kreiner G
    Conference:
    13-th Transgenic Technology Meeting, Praga (Czechy) (year: 2016, pages: Transgenic Res, vol 25(2), 203), Publisher: Transgenic Research / Springer
    Date:
    conference 20-23.03
    Status:
    Published
    DOI:
    link to the publication
  7. The effects of trehalose administration on autophagy enhancement in mice with conditional and progressive degeneration of medial spiny neurons

    Authors:
    Kreiner G, Rafa-Zabłocka K, Bagińska M, Nalepa I
    Conference:
    12-th International Congress of Polish Neuroscience Society, Gdańsk, Polska (year: 2015, pages: Abstract book, S102, P14.10), Publisher: n/a
    Date:
    conference 6-8.09
    Status:
    Published
  8. Nucleolar stress: new insights into the molecular mechanisms of Parkinson's disease

    Authors:
    Kreiner G
    Conference:
    Neurochemical Conference 2013 Emerging topics in neurological diseases: molecular mechanisms, diagnosis and therapy, Warszawa, Polska (year: 2013, pages: Folia Neuropathol 51, 373), Publisher: Folia Neuropathol
    Date:
    conference 24-25.10
    Status:
    Published
  9. Involvement of noradrenergic system in Parkinson's disease - study on novel transgenic mouse models

    Authors:
    Rafa-Zabłocka K, Jurga A, Baginska M, Parlato R, Schuetz G, Nalepa I, Kreiner G
    Conference:
    27th ECNP Congress, Berlin, Niemcy (year: 2014, pages: Eur Neuropsychopharmacol, vol 24, p. S642-S643), Publisher: Eur Neuropsychopharmacol
    Date:
    conference 18-21.10
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski